Seroprevalence of antibodies to the hepatitis C virus in Singapore.
Southeast Asian J Trop Med Public Health
;
1991 Dec; 22(4): 581-5
Artículo
en Inglés
| IMSEAR
| ID: sea-31972
ABSTRACT
The prevalence of antibodies to the hepatitis C virus (anti-HCV) in Singapore was assessed using a recombinant-based enzyme linked immunoassay system. 1004 serum samples were obtained from normal subjects (463), hemodialysis patients (112), hepatitis B virus (HBV) carriers (188), patients with hepatocellular carcinoma (HCC) (58) and patients with non-hepatitis B virus related liver diseases (183). Anti-HCV was found to be positive in 1.7% of healthy subjects, and in 20% of patients on regular hemodialysis. Three percent of HBV carriers were positive for anti-HCV. Twelve percent of patients with acute hepatitis with no known causes and 20% patients with chronic hepatitis with no known causes were positive for anti-HCV. Among patients with cirrhosis for which no known causes were found 33% were positive for anti-HCV. Thirty six percent of patients with HCC not associated with the presence of HBsAg were positive of anti-HCV. None of the patients with known causes of liver disease were positive for anti-HCV.
Texto completo:
Disponible
Índice:
IMSEAR (Asia Sudoriental)
Asunto principal:
Femenino
/
Humanos
/
Masculino
/
Adolescente
/
Hepacivirus
/
Adulto
/
Hepatopatías
/
Persona de Mediana Edad
/
Anticuerpos
Idioma:
Inglés
Revista:
Southeast Asian J Trop Med Public Health
Año:
1991
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS